The Clinical Trials Market 2006

Published Febraury 2006

The global clinical trials industry is currently worth an estimated $10 billion and has the potential for considerable growth in the future. Global revenues from clinical trials have increased by almost 15% in the last year and the industry is prepared for an extended period of healthy growth. Concern over safety and an extremely competitive pharmaceutical market has driven demand for large clinical trials but will also radically change how clinical trials are regulated and designed. This report discusses the dynamic future of the clinical trials market.

Will the current trend to outsource clinical trials to Asia be successful? How will the emerging discipline of pharmacogenomics affect drug development in the future? What kind of restrictions will authorities such as the FDA and the EMEA impose in the future? Read visiongain's brand new report to find out.

Further Information: http://www.marketreports.com/X2397.html